BRICKELL BIOTECH, INC. Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • April 14th, 2020 • Brickell Biotech, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 14th, 2020 Company Industry JurisdictionBrickell Biotech, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc. (the “Agent”) as follows: